| New approaches to therapy with omega-3 fatty acids. | |
| | |
MedLine Citation:
|
PMID: 18366989 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
With greater focus on chronic disease prevention, renewed attention has been directed toward understanding the pathophysiology of various medical conditions and the development of newer medical treatments to prevent and treat complications. There has been immense interest in evaluating societal lifestyles, cultural attitudes toward health, and dietary influences on health conditions. The omega-3 fatty acids have become a focus of interest, and recent research and trial evidence have highlighted their effects, including potential clinical advantages. Despite this progress, the precise mechanisms through which omega-3 fatty acids act remain poorly understood. These agents are now recommended as secondary prevention after acute myocardial infarction, and ongoing large clinical trials should provide insight into the use of omega-3 fatty acids in heart failure and the primary prevention of cardiovascular disease. |
| | |
Authors:
|
Puneet Kakar; Timothy Watson; Gregory Y H Lip |
Related Documents
:
|
20188069 - Sdd17 desaturase can convert arachidonic acid to eicosapentaenoic acid in mammalian cells. 19571329 - Whole-body synthesis secretion of docosahexaenoic acid from circulating eicosapentaenoi... 18199999 - Ethyl-eicosapentaenoic acid in first-episode psychosis. a 1h-mrs study. 21056289 - High α-linolenic acid and fish oil ingestion promotes ovulation to the same extent in ... 2150519 - Nervonic acid versus tricosanoic acid as internal standards in quantitative gas chromat... 19786119 - Omega-3 fatty acids are oxygenated at the n-7 carbon by the lipoxygenase domain of a fu... 10580109 - Biosynthetic origin of syringomycin and syringopeptin 22, toxic secondary metabolites o... 7580859 - An amino-terminal deletion of rice phytochrome a results in a dominant negative suppres... 16122259 - Synthesis of the side chain cross-linked tyrosine oligomers dityrosine, trityrosine, an... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current atherosclerosis reports Volume: 10 ISSN: 1534-6242 ISO Abbreviation: Curr Atheroscler Rep Publication Date: 2008 Feb |
Date Detail:
|
Created Date: 2008-03-27 Completed Date: 2008-05-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100897685 Medline TA: Curr Atheroscler Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 79-87 Citation Subset: IM |
Affiliation:
|
University Department of Medicine, City Hospital, Birmingham B18 7QH, UK. g.y.h.lip@bham.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arrhythmias, Cardiac
/
physiopathology Blood Platelets / physiology Blood Pressure / drug effects Cardiovascular Diseases / mortality, physiopathology, prevention & control Cell Adhesion Molecules / physiology Endothelium, Vascular / drug effects, physiology Fatty Acids, Omega-3 / pharmacology*, therapeutic use* Fibrinolysis / drug effects Fish Oils / therapeutic use Humans Myocardial Infarction / prevention & control Plant Oils / therapeutic use Randomized Controlled Trials as Topic Stroke / prevention & control Survival Analysis |
| Chemical | |
Reg. No./Substance:
|
0/Cell Adhesion Molecules; 0/Fatty Acids, Omega-3; 0/Fish Oils; 0/Plant Oils |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rimonabant: new data and emerging experience.
Next Document: Liver X receptors as therapeutic targets in metabolism and atherosclerosis.